Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-041053
Date:2022-07-05
Issuer: FATE THERAPEUTICS INC (FATE)
Original Submission Date:

Reporting Person:

PLAVSIC MARK
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE SAN DIEGO, CA 92131

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-07-05 S 3,719 d $24.61 127,123 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 9,500 shares of common stock underlying restricted stock units granted to the reporting person on june 14, 2021. this sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
f2 represents the weighted average sale price of the shares sold from $24.34 to $24.82 per share. the reporting person will provide, upon request by the commission staff, the issuer or a security holder of he issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2.
WhaleWisdom Logo

Elevate your investments